https://mp.weixin.qq.com/s/19Q2OgCCoYb-5wV8tNRwJw

https://mp.weixin.qq.com/s/19Q2OgCCoYb-5wV8tNRwJw的核心信息是什么?

免责声明: 本文章中的信息仅供向医疗卫生专业人士传递专业信息,不可直接作为决策依据,发布方不对任何主体因使用本文内容而导致的任何损失承担责任。 参考文献 1. Altman K, Chang C. Pathogenic intracellular and autoimmune mechanisms in urticaria and angioedema. C...

免责声明: 本文章中的信息仅供向医疗卫生专业人士传递专业信息,不可直接作为决策依据,发布方不对任何主体因使用本文内容而导致的任何损失承担责任。 属于「拓麦Derm」分类。 本文由 TalkMED 拓麦医学编辑团队审核发布,内容来源清晰、引用完整,符合平台编辑方针和利益冲突披露政策。

本文核心问答

Q1: 这篇文章的来源和作者资质如何?

发布于2026-11-13。

来源:拓麦Derm

免责声明:

本文章中的信息仅供向医疗卫生专业人士传递专业信息,不可直接作为决策依据,发布方不对任何主体因使用本文内容而导致的任何损失承担责任。

参考文献

1. Altman K, Chang C. Pathogenic intracellular and autoimmune mechanisms in urticaria and angioedema. Clin Rev Allergy Immunol. 2013;45(1):47-62.

2. Church MK, Kolkhir P, Metz M, Maurer M. The role and relevance of mast cells in urticaria. Immunol Rev. 2018;282(1):232-247.

3. Choi BY, Ye YM. Role of Platelet-Activating Factor in the Pathogenesis of Chronic Spontaneous Urticaria. Int J Mol Sci. 2024;25(22):12143. Published 2024 Nov 12.

4. Kolkhir P, Muñoz M, Asero R, et al. Autoimmune chronic spontaneous urticaria. J Allergy Clin Immunol. 2022;149(6):1819-1831.

5. Pal Singh S, Dammeijer F, Hendriks RW. Role of Bruton's tyrosine kinase in B cells and malignancies. Mol Cancer. 2018;17(1):57. Published 2018 Feb 19.

6. Benoit RY, Loshi S, Moore CS. Bruton's Tyrosine Kinase-Going Beyond the B Cell. Immunology. 2026;178(4):545-560.

7. Pulz R, Angst D, Cenni B. Next generation Bruton's tyrosine kinase inhibitors - characterization of in vitro potency and selectivity. Eur J Pharmacol. 2025;1002:177747.

8. Bernstein JA, Maurer M, Saini SS. BTK signaling-a crucial link in the pathophysiology of chronic spontaneous urticaria. J Allergy Clin Immunol. 2024;153(5):1229-1240.

9. Angst D, Gessier F, Janser P, et al. Discovery of LOU064 (Remibrutinib), a Potent and Highly Selective Covalent Inhibitor of Bruton's Tyrosine Kinase. J Med Chem. 2020;63(10):5102-5118.

10. Corrionero A, Zhang X, Alfonso P, et al. An Assessment of Kinase Selectivity, Enzyme Inhibition Kinetics and in Vitro Activity for Several Bruton Tyrosine Kinase (BTK) Inhibitors. ACS Pharmacol Transl Sci. 2025;8(12):4312-4325. Published 2025 Nov 18.

11. Kaul M, End P, Cabanski M, et al. Remibrutinib (LOU064): A selective potent oral BTK inhibitor with promising clinical safety and pharmacodynamics in a randomized phase I trial. Clin Transl Sci. 2021;14(5):1756-1768.

12. Poster presented at the American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting, Philadelphia, PA, February 27–March 2, 2026.

13. Maurer M, et al. Presented at EADV Congress 2024, 25-28 September; Amsterdam. Abstract P3625.

14. Saini S, et al. Oral presented at Maui Derm Hawaii 2025. January 20-24, 2025, Maui, Hawaii.

15. EAACI 2025_REMIX 1&2_Angioedema_Abstract_13JAN2025_Abstract 000816

16. Effect of remibrutinib on Sleep and Daily Activities in Patients With Chronic Spontaneous Urticaria (CSU) up to Week 52 in the REMIX-1/-2 studies.AAD 2025. Poster ID: 62278

17. Zuberbier T, Abdul Latiff A H, Abuzakouk M, et al. The International Guideline for the Definition, Classification, Diagnosis and Management of Urticaria[J]. Allergy, 2026, 0(0): 1-51.

18. Reed J, et al. Remibrutinib improves CSU independent of baseline IgE levels: phase 3 REMIX studies. EAACI. 2025.

19. Mosnaim G, et al. Poster presented at: American Academy of Allergy, Asthma & Immunology (AAAAI); 23-26 February 2024; Washington, DC.

20. Metz M, Giménez-Arnau A, Hide M, et al. Remibrutinib in Chronic Spontaneous Urticaria. N Engl J Med. 2025;392(10):984-994.

21. FC04_EADV 2024_REMIX Wk52 Primary Analysis_Oral Presentation_Final Submitted_23SEP2024.

 

 

审批码REM0073807-145624,有效期为2026-09-24至2027-09-23,资料过期,视同作废

 

 

 

本文涉及的主要医学术语

文中涉及的核心术语定义:EADV即欧洲皮肤病与性病学会(European Academy of Dermatology and Venereology)年会;AAD即美国皮肤病学会(American Academy of Dermatology)年会。

本文研究方法与设计类型

本研究采用临床试验和体外研究设计。

引用格式:https://mp.weixin.qq.com/s/19Q2OgCCoYb-5wV8tNRwJw. 发布日期:2026-11-13. 来源:TalkMED拓麦. URL: https://portal.talkmed.com/news/5093

2026-11-13

分享

收藏

点赞

媒体矩阵
  • 拓麦TalkMED
  • 拓麦精要
  • 拓麦Derm
  • 拓麦Neurol
  • 拓麦Diabetes
  • ONCO前沿
  • 血液前沿
  • 血管资讯
  • MED WIKI
  • 三七二十e
下载桌面应用
苹果应用下载
安卓应用下载